Inhaled insulin shows safety and high treatment satisfaction in youth with type 1 diabetes over 26 weeks but does not meet ...

ORLANDO, Fla. — The inhaled insulin Afrezza combined with a long-acting basal analog offers a non-inferior insulin treatment option for people with type 1 diabetes, new phase 4 data suggest. Afrezza ...

AID systems combine an insulin pump with a continuous glucose monitor to automatically adjust insulin levels throughout the day. Learn more about how they work.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Among 35 adults using technosphere insulin in the INHALE ...

The twiist AID system is designed to directly measure the volume and flow of insulin with every micro-dose, and address an individual’s dosing needs. Using the FDA-cleared Tidepool Loop technology, ...

The prescription-only device works with integrated continuous glucose monitors and alternate controller enabled pumps. The Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated ...

A clinical trial found that metformin, a drug typically used for type 2 diabetes, reduced insulin requirements by around 12% ...

Embecta has secured an FDA clearance for its first wearable insulin delivery system, with a patch pump designed for people with either Type 1 or Type 2 diabetes. The fully disposable device includes a ...